No Detail Found!

A novel approach for the quantification of paclitaxel loaded in ethyl cellulose/kollicoat and ethylcellulose/eudragit colloidal particles byuplc-pda

Author(s)
Mahvash Ansari Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Nazar Mohammad Ranjha Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Muhammad Hanif Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Muqadus Un Nisa Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Hassan Ali Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Ali M Alqahtani College of Pharmacy, King Khalid University,Abha Aseer,Saudi Arabia
Taha Alqahtani College of Pharmacy, King Khalid University,Abha Aseer,Saudi Arabia
Barkat A Khan Faculty of Pharmacy, Gomal University D.I.,Khan,Pakistan
Abstract
An optimized rapid reversed phase ultra-performance liquid chromatography (UPLC-PDA) method has been developed and validated for precise and accurate quantification of paclitaxel in drug delivery systems. The chromatographic separation was attained on L1 (USP) column (2.1 ×50 mm, 1.7µm) with an isocratic mobile phase comprised of acetonitrile and water (1:1; flow rate 0.6 mL/min) and detection was executed at 227 nm by PDA detector. The proposed UPLC-PDA method is found to be rapid with retention time of 1.37 min, selective with homogenous peaks and sensitive with Limit of Detection (LOD) of 0.08µg/mL and Limit of Quantification (LOQ) of 2.6µg/mL. The method showed excellent linearity (R2>0.998) over the range of 0.1 to 0.4mg/mL and applied for the paclitaxel quantification in different formulations with no inference of excipients. Thus, the proposed approach has potential for rapid estimation of drug purity, assay and release profile from pharmaceutical preparations.
Publication Details
Page(s) 1275-1280
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S4, Year: 2022

Request the full text from PASTIC

Keywords
validated approach, Paclitaxel, UPLC-PDA, rapid estimation, Application
References
Andersen A,Warren DJ,Brunsvig PF,Aamdal S,Kristensen GB,Olsen H GB .2006 .High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin. Pharmacol, 6(2) : 1472.
Bardelmeijer HA,Ouwehand M,Beijnen JH,Schellens JHM,Tellingen OV .2004 .Efficacy of novel Pglycoprotein inhibitors to increase the oral uptake of paclitaxel in mice. Invest. New Drugs, 22 : 219-229.
Foa R,Norton L,Seidman AD .1994 .Taxol (paclitaxel): A novel anti-microtubule agent with remarkable anti-neoplastic activity. Int. J. Clin. Lab. Res., 24(1) : 6-14.
Gao P,Rush BD,Pfund WP,Huang T,Bauer JM,Morozowich M,Kuo MS,Hageman MJ MS .2003 .Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci., 92(12) : 2386-98.
ICH .2005 .Guideline-Validation of Analytical Procedures:Text and Methodology Q2(R1), Current Step 4 version. , : .
Jain A,Gulbake A,Jain A,Shilpi A,Hurkat P,Kashaw S,Jain S S .2014 .Development and validation of the hplc method for simultaneous estimation of paclitaxel and topotecan. J. Chromatogr. Sci., 52(7) : 697-703.
Javed A,Kanchan K,Showkat RM,Saima A .2013 .Development and validation of RP-HPLC method for analysis of novel self-emulsifying paclitaxel formulation. Research and Reviews: J. Pharm. Anal, 2(3) : 17-27.
Kesharwani P,Tekade RK,Jain NJ .2011 .Spectrophotometric estimation of paclitaxel. Int. J. Adv. Pharm. Sci. 2, (1) : 29-32.
Montazeri AS,Mohammadi A,Adib N,Naeemy A .2018 .Development and validation of a stabilityindicating HPLC method for the determination of acarbose in pharmaceutical dosage forms. J. Anal. Chem, 73(9) : 910-916.
Mowafy H,Alanazi F,Alsarra IA,Maghraby GE,Kazi M .2012 .Method for determination of paclitaxel in rabbit plasma. Asian J. Chem, 24(8) : 3352-3356.
Musteata FM,Pawliszyn J .2006 .Determination of free concentration of paclitaxel in liposome formulation. J. Pharm. Pharm. Sci., 9(2) : 231-237.
Prashanth S,Kumar AA,Madhu B,Sagar JV B .2011 .LC and LC-MS study on stress decomposition behavior of paclitaxeland establishment of validated stabilityindicating assay method. Int. J. Pharm. Sci. Drug Res., 3(3) : 188-196.
Pyla S,Srinivas K,Yvv J,Panda J .2013 .Development and validation of new analytical method for paclitaxel in bulk and pharmaceutical dosage form by reverse phase HPLC (RP-HPLC). Int. J. Pharm. Bio. Sci., 4(3) : 534-540.
Sathyamoorthy N,Naveena VSH,Rajendran V,Dhanaraju MD .2014 .An approach for validated RPHPLC method for the analysis of paclitaxel in rat plasma. J. Appl. Pharm., 4(9) : 73-76.
Siddiqui S,Pallwal S,Kohi K,Siddiqui AA,Sahu K AA .2012 .RP-HPLC method for estimation and stress degradation study of paclitaxel as per ICH guidelines. J. Chromat. Separation Techniq, 3(4) : 1-4.
Srinivasa MS,Chandan RS,Koganti VS .2017 .Validated RP-UFLC method development of paclitaxel in pure and pharmaceutical dosage form. Pharm Methods, 8(1) : 155-159.
Wang F,Porter M,Konstantopoulos A,Zhang P,Cui H P .2017 .Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. J. Control. Release, 267(3) : 100-118.
Zhai J,Luwor R B,Ahmed N,Escalona R,Tan FH,Fong C,Ratcliffe J,Scoble JA,Drummond C J,Tran N C J .2018 .Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer. ACS Appl. Mater. Interfaces, 10(30) : 25174-25185.
0

Citations

0

Downloads

11

Views